Publications by authors named "Dara L Aisner"

96Publications

Molecular Pathology Economics 101: An Overview of Molecular Diagnostics Coding, Coverage, and Reimbursement: A Report of the Association for Molecular Pathology.

J Mol Diagn 2020 Aug 3;22(8):975-993. Epub 2020 Jun 3.

EAC101 Working Group, a Working Group of the Association for Molecular Pathology Economic Affairs Committee, Rockville, Maryland; Department of Pathology, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2020.05.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267794PMC
August 2020

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.

J Vis Exp 2019 07 5(149). Epub 2019 Jul 5.

Department of Pathology, University of Colorado - Anschutz Medical Campus;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3791/59895DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939769PMC
July 2019

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

J Thorac Oncol 2019 09 20;14(9):1666-1671. Epub 2019 Jun 20.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708730PMC
September 2019

Wake Up and Smell the Fusions: Single-Modality Molecular Testing Misses Drivers.

Clin Cancer Res 2019 08 3;25(15):4586-4588. Epub 2019 Jun 3.

Department of Pathology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-19-1361DOI Listing
August 2019

Ready or Not, Here I Come: Inflammatory Myofibroblastic Tumors With Kinase Alterations Revealed Through Molecular Hide and Seek.

J Thorac Oncol 2019 05;14(5):758-760

Department of Pathology, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.006DOI Listing
May 2019

DNA-Based versus RNA-Based Detection of MET Exon 14 Skipping Events in Lung Cancer.

J Thorac Oncol 2019 04 9;14(4):737-741. Epub 2019 Jan 9.

Department of Pathology, Division of Pathology, University of Colorado-Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.12.020DOI Listing
April 2019

Inter- and intra-tumor heterogeneity of SMAD4 loss in head and neck squamous cell carcinomas.

Mol Carcinog 2019 05 16;58(5):666-673. Epub 2019 Jan 16.

Department of Pathology, School of Medicine, Molecular Biology Program, Medical Scientist Training Program, University of Colorado, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22958DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637962PMC
May 2019

Precision Medicine in Non-Small Cell Lung Cancer: Current Standards in Pathology and Biomarker Interpretation.

Am Soc Clin Oncol Educ Book 2018 May;38:708-715

From the University of Michigan, Ann Arbor, MI; University of Colorado Cancer Center, Denver, CO; Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_209089DOI Listing
May 2018

Broad-Based Molecular Testing for Lung Cancer: Precisely the Time for Precision.

JAMA 2018 08;320(5):445-446

University of Colorado Cancer Center, University of Colorado, Denver, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2018.10096DOI Listing
August 2018

Comparison of Molecular Testing Modalities for Detection of ROS1 Rearrangements in a Cohort of Positive Patient Samples.

J Thorac Oncol 2018 10 20;13(10):1474-1482. Epub 2018 Jun 20.

Department of Medicine - Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.05.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286810PMC
October 2018

The Revised College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline: A Step Forward for Molecular Cytopathology.

Authors:
Dara L Aisner

Arch Pathol Lab Med 2018 06 29;142(6):684-685. Epub 2018 Mar 29.

From the Department of Pathology, University of Colorado School of Medicine, Aurora.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2018-0081-EDDOI Listing
June 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Small-cell transformation of -rearranged non-small-cell adenocarcinoma of the lung.

Cold Spring Harb Mol Case Stud 2018 04 2;4(2). Epub 2018 Apr 2.

Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont 05401, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002394DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880261PMC
April 2018

Validation of a Targeted RNA Sequencing Assay for Kinase Fusion Detection in Solid Tumors.

J Mol Diagn 2017 09 9;19(5):682-696. Epub 2017 Aug 9.

Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; Department of Internal Medicine, Division of Medical Oncology, The Ohio State University, Columbus, Ohio. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2017.05.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975628PMC
September 2017

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Tolerable and Effective Combination of Full-Dose Crizotinib and Osimertinib Targeting MET Amplification Sequentially Emerging after T790M Positivity in EGFR-Mutant Non-Small Cell Lung Cancer.

J Thorac Oncol 2017 07 6;12(7):e85-e88. Epub 2017 Mar 6.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.020DOI Listing
July 2017

Dramatic Response to Crizotinib in a Patient with Lung Cancer Positive for an Gene Fusion.

JCO Precis Oncol 2017 29;2017(1). Epub 2017 Aug 29.

Department of Pathology, University of Colorado - Anschutz Medical Campus, Aurora CO.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844276PMC
http://dx.doi.org/10.1200/PO.17.00117DOI Listing
August 2017

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2017 Mar 7;141(3):437-444. Epub 2016 Nov 7.

From the Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, Minnesota (Drs Roden, Aubry, and Yi); the Department of Pathology, University of Colorado, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology and Genomic Medicine, Methodist Hospital, Houston, Texas (Drs Barrios, Cagle, Ge, and Miller); the Department of Pathology, Mount Sinai Health System, Icahn School of Medicine, New York, New York (Dr Beasley); the Department of Pathology, University of São Paolo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); Département de Biopathologie, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, La Tronche, France (Dr Lantuejoul); the Department of Pathology, New York University Langone Medical Center, New York, New York (Dr Moreira); the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale (Dr Smith); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0459-SADOI Listing
March 2017

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Aug 19;140(8):825-9. Epub 2016 May 19.

From the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York, New York, and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, France, and J Fourier University-INSERM U 823-Institut A Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, VU Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0163-SADOI Listing
August 2016

Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene status.

Lung Cancer 2016 06 26;96:27-32. Epub 2016 Mar 26.

Department of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2016.03.007DOI Listing
June 2016

Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 11 15;140(11):1267-1272. Epub 2016 Apr 15.

From the Department of Pathology, University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York (Drs Borczuk and Cagle); the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, University Health Network, Princess Margaret Cancer Centre, and the University of Toronto, Toronto, Ontario, Canada (Drs da Cunha Santos and Tsao); the Department of Pathology, Massachusetts General Hospital, and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School, and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, and J Fourier University, Institut National de la Santé et de la Recherche Médicale-Institut Albert Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, New York University, New York (Dr Moreira); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York (Dr Rekhtman); the Department of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston (Drs Sholl and Vivero); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0091-SADOI Listing
November 2016

An Activating KIT Mutation Induces Crizotinib Resistance in ROS1-Positive Lung Cancer.

J Thorac Oncol 2016 08 9;11(8):1273-1281. Epub 2016 Apr 9.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, University of Colorado, Aurora, Colorado. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961521PMC
August 2016

A Suggested Molecular Pathology Curriculum for Residents: A Report of the Association for Molecular Pathology.

J Mol Diagn 2016 Mar 5;18(2):153-62. Epub 2016 Feb 5.

Molecular Pathology Curriculum for Residents Task Force of the Association for Molecular Pathology Training & Education Committee, Bethesda, Maryland; Molecular Diagnostics Laboratory, Emory University Hospital, Atlanta, Georgia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.10.006DOI Listing
March 2016

HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers.

J Thorac Oncol 2016 Mar 24;11(3):414-9. Epub 2015 Dec 24.

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Molecular Diagnostics Service, Department of Pathology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.10.025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698879PMC
March 2016

Targeting the WNT Signaling Pathway in Cancer Therapeutics.

Oncologist 2015 Oct 25;20(10):1189-98. Epub 2015 Aug 25.

Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore; Division of Medical Oncology and Department of Pathology, University of Colorado Denver, Aurora, Colorado, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2015-0057DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4591954PMC
October 2015

Rearranging Detection of Gene Rearrangements.

J Thorac Oncol 2015 Aug;10(8):1129-30

*Department of Pathology, and †Department of Medicine, Division of Medical Oncology, University of Colorado - Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000603DOI Listing
August 2015

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas.

J Neuropathol Exp Neurol 2015 Jul;74(7):743-54

From the Molecular Oncology Research Center (APB, ACC, AP, RMR), and Department of Pathology (CSN), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Cancer Center (JS, DLA), and School of Medicine (EM, MVG), University of Colorado, Aurora, Colorado; Department of Neurosurgery(CC), Barretos Cancer Hospital, Barretos, São Paulo, Brazil; Department of Surgery (RSO), and Department of Pathology and Forensic Medicine (APB, LN), Faculty of Medicine of Ribeirão Preto, University of São Paulo (FMRP-USP), São Paulo, Brazil; Life and Health Sciences Research Institute (ICVS), Health Sciences School, University of Minho (RMR), Braga, Portugal; and ICVS/3B's - PT Government Associate Laboratory(RMR), Braga/Guimarães, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NEN.0000000000000213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470527PMC
July 2015

Rociletinib in EGFR-mutated non-small-cell lung cancer.

N Engl J Med 2015 Apr;372(18):1700-9

From Massachusetts General Hospital (L.V.S., R.S.H., J.L., Z.P.), Harvard Medical School (L.V.S., G.R.O., R.S.H., Z.P.), and Dana-Farber Cancer Institute (G.R.O.) - all in Boston; the Drug Development Department, Université Paris-Sud, Gustave Roussy Cancer Campus (J.-C.S.), and Institut Gustave Roussy (A.V.), Villejuif - both in France; the David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (J.W.G., E.B.G., M.A.M., S.N.), and Stanford Cancer Institute, Stanford University, Stanford (H.A.W., J.W.N.) - both in California; the Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit (S.M.G., C.G., A.J.W.); University of Texas M.D. Anderson Cancer Center, Houston (V.P.); the Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.J.S.); the Medical University of Gdansk, Gdansk, Poland (R.D.); the University of Colorado (D.L.A., D.R.C.) and University of Colorado Cancer Center (R.C.D.) - both in Aurora; and Clovis Oncology, San Francisco (M.R., C.A.K., S.J.-T., S.L.M., A.R.A.), Boulder, CO (J.I., D.D.), and Cambridge, United Kingdom (L.R.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1413654DOI Listing
April 2015

BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation.

Am J Surg Pathol 2015 Apr;39(4):528-40

Departments of *Pathology †Neurosurgery ‡Neurology §Pediatrics, The University of Colorado School of Medicine ∥Children's Hospital Colorado, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000363DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617316PMC
April 2015

Giant pulmonary chondroid hamartoma: imaging and pathology correlation of a rare tumor demonstrated with bone scintigraphy and 18F-FDG PET/CT.

Clin Nucl Med 2015 Jan;40(1):79-81

From the Departments of *Radiology, and †Pathology, University of Colorado School of Medicine, Aurora, CO; ‡Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD; and §Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Colorado School of Medicine, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000000599DOI Listing
January 2015

Massive dissemination from spinal cord gangliogliomas negative for BRAF V600E: report of two rare adult cases.

Am J Clin Pathol 2014 Aug;142(2):254-60

From the Department of Pathology, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO; Department of Neurosurgery, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO; and Department of Neurology, Anschutz Medical Campus, University of Colorado at Denver, Aurora, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPIBSV67UVJRQVDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616006PMC
August 2014

EGFR exon 19 deletion mutations and systemic/central nervous system miliary metastasis: clinical correlations and response to therapy.

Clin Lung Cancer 2014 Sep 15;15(5):387-9. Epub 2014 May 15.

Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.04.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160348PMC
September 2014

Is there clinical value to prognostic signatures in early-stage NSCLC?

Clin Cancer Res 2014 Apr 28;20(7):1727-9. Epub 2014 Feb 28.

Authors' Affiliations: Division of Medical Oncology, Departments of Medicine and Pathology, University of Colorado Cancer Center, University of Colorado Denver, Aurora, Colorado.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-3387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998101PMC
April 2014

Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer.

J Thorac Oncol 2014 Mar;9(3):e21-3

*Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Tongji University Institute, People's Republic of China; †Department of Medicine, Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado; and ‡Department of Pathology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153022
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117236PMC
March 2014

Erlotinib response in an NSCLC patient with a novel compound G719D+L861R mutation in EGFR.

J Thorac Oncol 2013 Sep;8(9):e83-4

Departments of Medicine, Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31829ceb8dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154819PMC
September 2013

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Am J Surg Pathol 2013 May;37(5):685-98

Department of Pathology, The University of Colorado Health Sciences Center, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e31827f9c5eDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610349PMC
May 2013

Diagnostic assays for identification of anaplastic lymphoma kinase-positive non-small cell lung cancer.

Cancer 2013 Apr 20;119(8):1467-77. Epub 2012 Dec 20.

Division of Medical Oncology, University of Colorado Cancer Center, Anschutz Medical Campus, Aurora, Colorado, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.27913DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935240PMC
April 2013

Molecular Pathology of Non-Small Cell Lung Cancer.

Surg Pathol Clin 2012 Dec 30;5(4):903-18. Epub 2012 Sep 30.

Department of Pathology, University of Colorado Denver, 12631 E. 17th Avenue, Mail Stop B216, Aurora, CO 80045, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2012.08.006DOI Listing
December 2012

Anaplastic PXA in adults: case series with clinicopathologic and molecular features.

J Neurooncol 2013 Jan 25;111(1):59-69. Epub 2012 Oct 25.

Department of Pathology, The University of Colorado Health Sciences Center, 12605 E. 16th Avenue, Room 3026, MS F768, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-012-0991-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617340PMC
January 2013

Molecular pathology of non-small cell lung cancer: a practical guide.

Am J Clin Pathol 2012 Sep;138(3):332-46

Department of Pathology, University of Colorado, Anschutz Medical Campus, 12801 East 17th Ave, Mail Stop 8104, Aurora, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1309/AJCPFR12WJKCEEZZDOI Listing
September 2012

The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.

Diagn Cytopathol 2012 Jun;40(6):511-24

Department of Pathology, Colorado Molecular Correlates Laboratory, University of Colorado Denver, Aurora, Colorado 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22820DOI Listing
June 2012

Prognostic patterns in the histopathology of pulmonary adenocarcinoma.

J Clin Oncol 2012 May 5;30(13):1401-3. Epub 2012 Mar 5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2011.40.3964DOI Listing
May 2012

The diagnostic efficacy of combining bronchoscopic tissue biopsy and endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of malignant lesions in the lung.

Diagn Cytopathol 2013 Nov 23;41(11):929-35. Epub 2012 Feb 23.

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/dc.22847DOI Listing
November 2013

Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer.

Clin Cancer Res 2012 Mar 10;18(5):1472-82. Epub 2012 Jan 10.

Division of Medical Oncology, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado 80209, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2906DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311875PMC
March 2012

Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization.

Am J Surg Pathol 2011 Dec;35(12):1894-901

Department of Pathology, Anschutz Medical Campus, University of Colorado, Denver, CO 80045, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3182382a3fDOI Listing
December 2011

Genetic testing for metastasis: potential for improved cancer treatment.

Future Oncol 2011 Jun;7(6):697-701

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.11.48DOI Listing
June 2011

Loss of S100 antigenicity in metastatic melanoma.

Hum Pathol 2005 Sep;36(9):1016-9

Laboratory of Pathology, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2005.07.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2656365PMC
September 2005

Telomerase regulation: not just flipping the switch.

Curr Opin Genet Dev 2002 Feb;12(1):80-5

The University of Texas Southwestern Medical Center, The Department of Cell Biology, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9039, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0959-437x(01)00268-4DOI Listing
February 2002